loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 761058 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Boehringer Ingelheim GmbH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ADALIMUMAB-ADBM (1)

    filter

    01 BOEHRINGER INGELHEIM (1)

    filter

    01 INJECTABLE;INJECTION (1)

    filter

    01 40MG/0.8ML (1)

    filter

    01 USA (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Germany
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Adalimumab-adbm

    PDF Supplier PDF
    URL Supplier Web Content
    INJECTABLE;INJECTION
    40MG/0.8ML
    CYLTEZO
    USA
    761058
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for CTD TGA MCC DOSSIER APPLICATION 761058

    Looking for CTD TGA MCC DOSSIER APPLICATION 761058 1

    19

    Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is ADALIMUMAB-ADBM, with a corresponding application number 761058 and regulatory information .

    proudly manufactured in the

    Boehringer Ingelheim GmbH's CYLTEZO INJECTABLE;INJECTION, medication with 40MG/0.8ML of ADALIMUMAB-ADBM.

    Post Enquiry
    POST ENQUIRY